Wells Fargo & Company Minerva Surgical Inc Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.16 - $0.3 $3 - $6	-23 Reduced 15.03%	130 $0
Q2 2023 Aug 15, 2023	BUY	$0.17 - $0.33 $1 - $1	6 Added 4.08%	153 $0
Q1 2023 May 12, 2023	BUY	$0.2 - $0.5 $17 - $44	88 Added 149.15%	147 $0
Q4 2022 Feb 13, 2023	BUY	$0.16 - $16.8 $0 - $16	1 Added 1.72%	59 $0
Q3 2022 Nov 14, 2022	BUY	$0.82 - $17.0 $13 - $272	16 Added 38.1%	58 $0
Q2 2022 Aug 12, 2022	BUY	$1.75 - $4.5 $5 - $13	3 Added 7.69%	42 $0
Q4 2021 Feb 14, 2022	BUY	$4.53 - $9.78 $176 - $381	39 New	39 $0

Ticker UTRS
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 28,860,000
Description
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation de...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.